Background: The clinical value of plasma circulating cell-free DNA (cfDNA)integrity as diagnostic biomarker in the patients with HCV related hepatocellular
carcinoma (HCC) was investigated and correlated with the commonly usedmarker alpha fetoprotein (AFP).
Aim of the work: To assess the plasmacirculating cell free DNA integrity versus AFP as a biomarker fordiagnosis of hepatocellularcarcinoma using ALU 115 and ALU 247 sequences.
“Context Hepatitis C virus (HCV) is a common blood-borne pathogen that relies heavily on nucleic acid testing for confirmation of infection. Nucleic acid tests are invaluable for the diagnosis of HCV infection and provide critical prognostic information for guiding treatment and measuring the response to antiviral therapy”.
Context hepatitis C virus (HCV) may be a common blood-borne infectious agent that depends heavily on macromolecule testing for confirmation of infection. macromolecule tests ar valuable for the designation of HCV infection and supply essential prognostic data for guiding treatment and measurement the response to antiviral therapy”.
“Objective To review the presently obtainable molecular diagnostic tests for HCV, their clinical applications, and the way these tests shed lightweight on the explanation of HCV”,
“Evidence Acquisition Search of MEDLINE (1966 to July 2006), article reference lists, and national meeting abstracts for the designation and applications of molecular diagnostic tests for HCV. Studies were hand-picked on the idea of clinical relevance”.
“Evidence Synthesis Qualitative macromolecule tests have low limits of detection (<50 IU HCV RNA/mL) and ar used for confirmation of HCV infection and for screening blood donations. hepatitis C virus genotype take a look at results give necessary prognostic data associated with therapeutic response and ar habitually used for choosing treatment regimens. Quantitative HCV ribonucleic acid testing provides prognostic data concerning probability of treatment response and plays a vital role in observation the antiviral response to treatment. Sustained medicine response is outlined as testing negative for HCV ribonucleic acid half-dozen months once halt of medical aid. Recent studies counsel that the speed of response to medical aid is additionally necessary. for instance, conversion to associate HCV ribonucleic acid negative take a look at result once four weeks of medical aid constitutes a rapidvirological response and may be a robust predictor of treatment success. Patients WHO haven't had associate earlyvirological response, outlined as a minimum of a 2-log decline in HCV ribonucleic acid once twelve weeks of medical aid, ar unlikely to reply with an extra thirty six weeks of medical aid, and may stop therapy”.
Conclusions :
“A sensitive macromolecule take a look at ought to be accustomed make sure all cases of acute or chronic HCV infection. A genotype take a look at and quantitative HCV ribonucleic acid take a look at ought to be performed on all patients before medical aid to best assess chance of response and to assist in choice of applicable therapeutic program. observation HCV ribonucleic acid throughout treatment provides necessary data on probability of sustained medicine response. identical form of quantitative HCV ribonucleic acid take a look at ought to be used throughout a patient's treatment course”.
“Chronic hepatitis C virus (HCV) infection happens often within the us and worldwide. The Centers for unwellness management and bar estimates that a minimum of three.2 million persons within the us ar inveterately infected.1 within the one990s, a minimum of ten 000 deaths annually were directly thanks to hepatitis C, with a projection of a multiplication of the infectious disease C–related deaths by 2020.1,2Chronic hepatitis C is a vital and rising think about hepatoma and is currently the leading indication for liver transplantation.3 sadly, HCV infection is commonly underdiagnosed. over five hundredth of individuals at highest risk for HCV ar infected however ar unaware of their unwellness, resulting in unfold of the infection and lost treatment opportunities”.
“Molecular medicine techniques play a key role in designation and observation of treatment. as a result of it's troublesome to culture the virus, molecular techniques were instrumental in initial distinctive HCV, creating it one among the primary pathogens to be known strictly by molecular medicine.5 hepatitis C viral infection is confirmed by the detection of microorganism ribonucleic acid through macromolecule tests (NATs), and these tests ar accustomed monitor the response to antiviral medical aid. we have a tendency to review presently obtainable molecular diagnostic tests for HCV, their clinical applications, and the way these tests shed lightweight on the explanation and best management of hepatitis C. Readers ar brought up a previous review during this series for a a lot of general summary of the clinical management of hepatitis C.6”
“Evidence acquisition”
“We searched the MEDLINE info from 1966 to July 2006 for English-language articles victimization the subsequent search terms: HCV, infectious disease C/diagnosis, infectious disease C/virology, hepacivirus/physiology, infectious disease C/treatment, enzyme chain reaction/methods, enzyme chain reaction/standards, enzyme chain reaction, sensitivity and specificity, accuracy, genotype, virus replication. we have a tendency to more reviewed meeting abstracts from the 2006 yank Association for the Study of disease and also the European Association for the Study of the Liver for relevant articles. we have a tendency to based mostly our recommendations on laboratory designation and analysis on the 2002 National Institutes of Health agreement tips, the 2004 yank Association for the Study of disease observe tips, and also the 2003 Centers for unwellness management and bar Screening and Testing tips.7-9”
“Evidence synthesis”
Natural History of HCV Infection
“Among patients exposed to HCV, 15 August 1945 to four-hundredth can clear the infection inside half-dozen months10,11 (Figure 1). The remaining hour to eighty fifth of patients WHO still have detectable HCV ribonucleic acid for six months ar thought-about to be inveterately infected.8 A minority of inveterately infected patients can have persistently traditional aminoalkanoic acid transaminase (ALT) levels.13 As a result, ALT levels and a positive HCV medical science result aren't adequate for the designation of chronic HCV; instead, detection of HCV ribonucleic acid is needed to ascertain the designation. Results from longitudinal viraemia studies have indicated that spontaneous resolution of chronic HCV infections happens at a rate of zero.50% to 0.74% per person-year annually.14,15Unfortunately, up to twenty of people with chronic hepatitis C eventually develop liver cirrhosis of the liver, which can be sophisticated by hepatoma, internal organ decompensation, or death”.
Subjects and Methods:
It was a comparative study on eighty patientsrecruited from Cairo UniversityHospital Endemic medication department throughout the amount from Gregorian calendar month 2018 to September 2018. They were divided into 2 groups: forty HCC patients and 40HCV connected liver cirrhosis of the liver patients.AFP was measured by accelerator luminescence. Genetic analysis for determination of cfDNA integritywas done by analysingALU a hundred and fifteen and ALU 247 sequencesusing SYBR inexperienced based mostly period PCR.
Results:
HCV connected HCC patients had lower plasma cfDNA integrity than thosewith HCV connected liver cirrhosis of the liver patients (p price < zero.005). Also, there was a
statistical important correlational statistics between foetoprotein (measured by chemiluminescence) and plasma cfDNAintegrity with r price = -0.54 (P price <0.001). The AUCs for detection of HCCby cfDNA integrity and foetoprotein were zero.965 (P price < zero.001) and 0.886 (P < 0.001),respectively.
Conclusion: The results of this study prompt that the plasma cfDNA integritycan be used as a possible early marker for HCC among the HCV patients.Keywords: circulating cell-free DNA; cfDNA; integrity; hepatocellular carcinoma.
This work is partly presenting in 2nd International Conference on Molecular Pathology and Genomics on December 09-10, 2020 held at Paris, France.
PDFShare this article
Research and Reports in Medical Sciences received 13 citations as per Google Scholar report
